Mostrar el registro sencillo del ítem
dc.contributor.author
Villaverde, Marcela Solange
dc.contributor.author
Gil Cardeza, Maria Lourdes
dc.contributor.author
Glikin, Gerardo Claudio
dc.contributor.author
Finocchiaro, Liliana Maria Elena
dc.date.available
2022-07-18T13:28:44Z
dc.date.issued
2012-06
dc.identifier.citation
Villaverde, Marcela Solange; Gil Cardeza, Maria Lourdes; Glikin, Gerardo Claudio; Finocchiaro, Liliana Maria Elena; Interferon-Β lipofection II: Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-Β gene transfer to human tumor cells; Nature Publishing Group; Cancer Gene Therapy; 19; 6; 6-2012; 420-430
dc.identifier.issn
0929-1903
dc.identifier.uri
http://hdl.handle.net/11336/162317
dc.description.abstract
We evaluated the cytotoxic effects (apoptosis, necrosis and early senescence) of human interferon-B (hIFNB) gene lipofection. The cytotoxicity of hIFNB gene lipofection resulted equivalent to that of the corresponding addition of the recombinant protein (rhIFNB) on human tumor cell lines derived from Ewing´s sarcoma (EW7 and COH) and colon (HT-29) carcinomas. However, it was stronger than rhIFNB on melanoma (M8) and breast adenocarcinoma (MCF7). To reveal the mechanisms involved in these differences, we compared the effects of hIFNB gene and rhIFNB protein on EW7 and M8 (sensitive and resistant to rhIFNB protein, respectively). Lipofection with hIFNB gene caused a mitochondrial potential decrease simultaneous with an increase of oxidative stress in both cell lines. However, rhIFNB protein displayed the same pattern of response only in EW7-sensitive cell line. The great bystander effect of the hIFNB gene lipofection, involving the production of reactive oxygen species, would be among the main causes of its success. In EW7, this effect killed >60% of EW7 cell population, even though only 1% of cells were expressing the transgene. As hIFNB gene was effective even in the rhIFNB protein-resistant M8 cell line and in a way not limited by low lipofection efficiency, these results strongly support the clinical potential of this approach.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Nature Publishing Group
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
APOPTOSIS
dc.subject
EWING'S SARCOMA
dc.subject
INTERFERON-B
dc.subject
LIPOFECTION
dc.subject
MELANOMA
dc.subject
REACTIVE OXYGEN SPECIES
dc.subject.classification
Tecnologías que involucran la manipulación de células, tejidos, órganos o todo el organismo
dc.subject.classification
Biotecnología de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Interferon-Β lipofection II: Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-Β gene transfer to human tumor cells
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2022-06-21T18:33:02Z
dc.journal.volume
19
dc.journal.number
6
dc.journal.pagination
420-430
dc.journal.pais
Reino Unido
dc.journal.ciudad
Londres
dc.description.fil
Fil: Villaverde, Marcela Solange. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
dc.description.fil
Fil: Gil Cardeza, Maria Lourdes. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
dc.description.fil
Fil: Glikin, Gerardo Claudio. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
dc.description.fil
Fil: Finocchiaro, Liliana Maria Elena. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
dc.journal.title
Cancer Gene Therapy
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/cgt201219
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1038/cgt.2012.19
Archivos asociados